Study on Evaluation and Optimization of TCM Regimen of Generalized Anxiety Disorder

Xuanwu Hospital of Capital Medical University0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. Subjects aged 18-65 years;
•2. Patients with anxiety disorder in accordance with clinical research standards;
•3. Subjects who meet the TCM syndrome standards of liver stagnation and fire transforming type, blood stasis and internal resistance type, heart and gallbladder Qi deficiency type;
•4. Subjects with stable vital signs have clear mind and certain expression ability;
•5. The subjects who signed the informed consent agreed to participate in this study;
•Only those who meet the above five criteria can be selected.

•1. Patients with somatic diseases secondary to GAD;
•2. Subjects with unstable vital signs;
•3. Subjects with severe aphasia, agnosia and inability to communicate;
•4. Subjects with anxiety accompanied by other mental diseases (such as depression, obsession, schizophrenia, etc.) diagnosed by western medicine;
•5. Known alcoholics or substance dependent subjects;
•6. Patients with non anxiety psychosis diagnosed by western medicine;
•7. Subjects who used other drugs or therapies to treat anxiety disorder during the trial;
•8. Subjects who did not use drugs according to the regulations were unable to judge the efficacy or incomplete information, which affected the efficacy or safety judgment;
•9. Subjects who refused to take traditional Chinese medicine and had suicidal behavior;
•10. Subjects who had received anti anxiety treatment within one week before the trial;
•11. Subjects with severe hepatic and renal insufficiency;
•12. Pregnant and lactating women;
•Those meeting one of the above criteria will be excluded.

发起方

Xuanwu Hospital of Capital Medical University